SIRT7 and breast carcinoma: With regard to cancer, SIRT7 is responsible for tumor phenotype maintenance by deacetylation of histone H3 lysine 18 (H3K18) [12], and SIRT7 expression is upregulated in the majority of human cancers, including hepatic, gastric, colorectal, and breast cancers [13,14].